AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 78, Issue 5 564-566, Copyright © 1988 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kakar, F
Right arrow Articles by Strite, S A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kakar, F
Right arrow Articles by Strite, S A
Non-contraceptive estrogen use and the risk of gallstone disease in women.

F Kakar, N S Weiss and S A Strite

Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle 98195.

We interviewed 102 women, ages 41-74 years who underwent gallstone surgery between January 1979 and September 1980, and 98 controls selected from the membership files of a large prepaid health care plan in Western Washington, about their past use of certain medications, reproductive history, and physical and demographic characteristics. The risk of gallstone disease among women who used estrogens for at least one year prior to diagnosis of their condition, relative to that of other women, was 1.18 (95% CI: 0.65-2.13). Standardization for the effects of age, race, obesity, parity, thiazide use, and history of high blood pressure did not alter appreciably the estimate of relative risk. Among estrogen users, the duration of use was similar in cases and controls. Our findings suggest that if non-contraceptive estrogen use is a risk factor for gallstone disease (requiring surgery) in women, its effect is very small.




This article has been cited by other articles:


Home page
JAMAHome page
D. J. Cirillo, R. B. Wallace, R. J. Rodabough, P. Greenland, A. Z. LaCroix, M. C. Limacher, and J. C. Larson
Effect of Estrogen Therapy on Gallbladder Disease
JAMA, January 19, 2005; 293(3): 330 - 339.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
Cholecystitis, Biliary Tract Surgery, and Pancreatitis
Obstet. Gynecol., October 1, 2004; 104(4_suppl): 17S - 24S.
[Full Text] [PDF]


Home page
JAMAHome page
H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan
Postmenopausal Hormone Replacement Therapy: Scientific Review
JAMA, August 21, 2002; 288(7): 872 - 881.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. A. Simon, D. B. Hunninghake, S. K. Agarwal, F. Lin, J. A. Cauley, C. C. Ireland, J. H. Pickar, and for the Heart and Estrogen/progestin Replacement S
Effect of Estrogen plus Progestin on Risk for Biliary Tract Surgery in Postmenopausal Women with Coronary Artery Disease: The Heart and Estrogen/progestin Replacement Study
Ann Intern Med, October 2, 2001; 135(7): 493 - 501.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Public Health Association